Evidence map›Paper›PMID 38151328›Full record

ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2024

[Mutational Signatures Analysis of Micropapillary Components and Exploration of ZNF469 Gene in Early-stage Lung Adenocarcinoma with Ground-glass Opacities].

Youtao Xu, Qinhong Sun, Siwei Wang, Hongyu Zhu, Guozhang Dong, Fanchen Meng, Zhijun Xia, Jing You, Xiangru Kong, Jintao Wu and 10 more

Open access · greenAbstract readEnglish Abstract
In one paragraph

Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 1 country.

Youtao Xu *Department of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Qinhong Sun *Department of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Siwei Wang *Department of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Hongyu ZhuDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Guozhang DongDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Fanchen MengDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Zhijun XiaDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Jing YouDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Xiangru KongDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Jintao WuDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Peng ChenDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Fangwei YuanDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Xinyu YuDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Jinfu JiDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Zhitong LiDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Pengcheng ZhuDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Yuxiang SunDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Tongyan LiuDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Rong YinDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Lin XuDepartment of Thoracic Surgery, the Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, 
Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translation Cancer Research, Nanjing 210009, China.
Jiangsu Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn China, lung cancer remains the cancer with the highest incidence and mortality rate. Among early-stage lung adenocarcinomas (LUAD), the micropapillary (MPP) component is prevalent and typically exhibits high aggressiveness, significantly correlating with early metastasis, lymphatic infiltration, and reduced five-year survival rates. Therefore, the study is to explore the similarities and differences between MPP and non-micropapillary (non-MPP) components in malignant pulmonary nodules characterized by GGOs in early-stage LUAD, identify unique mutational features of the MPP component and analyze the relationship between the ZNF469 gene, a member of the zinc-finger protein family, and the prognosis of early-stage LUAD, as well as its correlation with immune infiltration.

methodsA total of 31 malignant pulmonary nodules of LUAD were collected and dissected into paired MPP and non-MPP components using microdissection. Whole-exome sequencing (WES) was performed on the components of early-stage malignant pulmonary nodules. Mutational signatures analysis was conducted using R packages such as maftools, Nonnegative Matrix Factorization (NMF), and Sigminer to unveil the genomic mutational characteristics unique to MPP components in invasive LUAD compared to other tumor tissues. Furthermore, we explored the expression of the ZNF469 gene in LUAD using The Cancer Genome Atlas (TCGA) database to investigate its potential association with the prognosis. We also investigated gene interaction networks and signaling pathways related to ZNF469 in LUAD using the GeneMANIA database and conducted Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Lastly, we analyzed the correlation between ZNF469 gene expression and levels of immune cell infiltration in LUAD using the TIMER and TISIDB databases.

resultsMPP components exhibited a higher number of genomic variations, particularly the 13th COSMIC (Catalogue of Somatic Mutations in Cancer) mutational signature characterized by the activity of the cytidine deaminase APOBEC family, which was unique to MPP components compared to non-MPP components in tumor tissues. This suggests the potential involvement of APOBEC in the progression of MPP components in early-stage LUAD. Additionally, MPP samples with high similarity to APOBEC signature displayed a higher tumor mutational burden (TMB), indicating that these patients may be more likely to benefit from immunotherapy. The expression of ZNF469 was significantly upregulated in LUAD compared to normal tissue, and was associated with poor prognosis in LUAD patients (P<0.05). Gene interaction network analysis and GO/KEGG enrichment analysis revealed that COL6A1, COL1A1, COL1A2, TGFB2, MMP2, COL8A2 and C2CD4C interacted with ZNF469 and were mainly involved in encoding collagen proteins and participating in the constitution of extracellular matrix. ZNF469 expression was positively correlated with immune cell infiltration in LUAD (P<0.05).

conclusionsThe study has unveiled distinctive mutational signatures in the MPP components of early-stage invasive LUAD in the Asian population. Furthermore, we have identified that the elevated expression of mutated ZNF469 impacts the prognosis and immune infiltration in LUAD, suggesting its potential as a diagnostic and prognostic biomarker in LUAD.

Indexed as

Adenocarcinoma of LungLung NeoplasmsChinaHumansPrognosisTranscription FactorsTranscription FactorsZNF469 protein, humanGround-glass opacitiesLung neoplasmsMicropapillaryMutational signatures analysisZNF469 gene

Identifiers

PMID38151328
PMCPMC10767650
OpenAlexW4390348246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.